India, Nov. 3 -- The company is a pharmaceutical manufacturing company engaged in producing active pharmaceutical ingredients (APIs), pharmaceutical formulation intermediates (PFIs) and finished dosage formulations (FDs). The company supplies medicines and pharmaceutical products to markets across North America, Europe and other international regions. Its product portfolio includes pharmaceutical ingredients and formulations used in therapeutic areas such as pain management and other treatments.

The Nifty 50 is trading at 23,632.15, up by 0.82%, while the Sensex gained to 76,410.91, up by 0.95% on Tuesday. The shares of Granules India are currently trading at Rs. 810.55, down by 1.30%. The company has a market capitalisation of Rs. 20,0...